ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0890

Granzyme K+ CD8 T cells colocalize with myeloid cells and activate them through several pathways

Julia Nicole Zeid1, Kaitlyn Arce2, Nanxi Guo1, Kartik Bhamidipati3, Kevin Wei4, Larry Moreland5, Fan Zhang6 and Anna Helena Jonsson2, 1University of Colorado School of Medicine, Aurora, 2University of Colorado School of Medicine, Aurora, CO, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 5University of Colorado, Denver, CO, 6The University of Colorado, Aurora, CO

Meeting: ACR Convergence 2025

Keywords: immunology, Monocytes/macrophages, rheumatoid arthritis, Synovitis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (0885–0890)

Session Type: Abstract Session

Session Time: 11:15AM-11:30AM

Background/Purpose: Granzyme K (GZMK)-expressing CD8 T cells have recently been detected in tissues from an increasing number of autoimmune conditions, but their role in disease pathogenesis is unclear. We have identified and characterized these cells in rheumatoid arthritis (RA), where they represent up to 30% of cells in inflamed synovium (joint lining) and express a gene program different from granzyme B (GZMB)+ cytotoxic CD8 T cells. We recently showed that Gzmk knock-out mice exhibit a milder course antigen-induced arthritis, a mouse model of inflammatory arthritis, compared to wildtype mice, supporting a direct role for GZMK in the pathogenesis of inflammatory arthritis such as RA. GZMK+ CD8 T cells have many potential effector functions. Resting GZMK+ CD8 T cells continuously release GzmK, even in the absence of stimulation. They can also release cytokines such as IFNγ upon T-cell receptor (TCR)- or cytokine-mediated stimulation. Lastly, GzmK can initiate complement cascades, generating anaphylatoxins C3a and C5a. Our goal with this project is to localize GZMK+ CD8 T cells in RA synovial tissue and characterize their molecular interactions with neighboring cells.

Methods: Spatial transcriptomic data were collected from three samples of human synovial tissue from patients with RA using a custom 377-probe panel on the Xenium platform (10x Genomics). For in vitro experiments, CD14+ myeloid cells isolated from human peripheral blood mononuclear cells by magnetic-activated cell sorting and stimulated with recombinant or serum-purified GZMK, IFNγ, C3a, and/or C5a, for 24 hours and then analyzed by ELISA or RT-PCR.

Results: In spatial transcriptomic and immunofluorescence microscopy data, GZMK+ CD8 T cells were preferentially located among myeloid cells in perivascular areas of the sublining in human RA synovial tissue (Figure 1). To investigate and compare molecular interactions between GZMK+ CD8 T cells and myeloid cells, we stimulated CD14+ blood monocytes in vitro with soluble factors produced by GZMK+ CD8 T cells directly (GZMK, IFNγ) or via activation of complement cascades (C3a, C5a). We paid special attention to chemokines CCL2, CCL4, CXCL9, and CXCL10 since both monocytes and GZMK+ CD8 T cells express the cognate receptors for these chemokines, CCR2, CCR5, and CXCR3. We found that recombinant GZMK induced monocytes to produce CCL2, CCL4, and IL-6 (Figure 2). GZMK did not induce CXCL9, CXCL10, or STAT1 on its own, but it amplified the ability of IFNγ to induce these classic interferon signature markers. The combination of GZMK and IFNγ also had modestly augmented effects on IL-1β and IL-6, while they dampened CCL2 production. C5a displayed more potent effects than C3a in terms of CCL2, CCL4, IL-1β, and IL-6 production.

Conclusion: GZMK+ CD8 T cells localize near myeloid cells in the sublining of inflamed RA synovium. GZMK can directly induce monocytes to secrete CCL2, CCL4, and IL-6, and it can act together with IFNγ or through complement cascades to induce IL-1β and interferon signature genes. Together, these molecular interactions form a strong positive feedback loop, recruiting and activating additional GZMK+ CD8 T cells and blood monocytes in inflamed RA synovium.

Supporting image 1Figure 1. GZMK+ CD8A+ cells are located near myeloid cells in the sublining of RA synovial tissue. FFPE RA synovial tissue was submitted for spatial transcriptomic analysis on the Xenium platform. The panels on the left show density gradients of transcripts encoding CD68 (myeloid marker) and GZMK, respectively, superimposed on the tissue. Red arrows point to areas enriched in both CD68 and GZMK. The panel on the right shows a close-up view with cells shaded by cluster, showing intermingling of GZMK+ T cells (teal) and myeloid cells (red).

Supporting image 2Figure 2. GZMK directly stimulates blood monocytes and also amplifies the effects of IFNγ. Human CD14+ monocytes were isolated from blood and stimulated with recombinant or serum-purified GZMK, IFNγ, C3a, or C5a, or a combination of GZMK and IFNγ for 24 hours. The supernatants were collected for analysis by ELISA, while the cells were lysed for analysis by quantitative RT-PCR. The lines connect samples from the same blood donor (N&#3f6).


Disclosures: J. Zeid: None; K. Arce: None; N. Guo: None; K. Bhamidipati: None; K. Wei: 10X Genomics, 5, anaptysbio, 2, Gilead, 5, Merck/MSD, 5, Mestag, 2, Pfizer, 2; L. Moreland: None; F. Zhang: None; A. Jonsson: Arpelos Biosciences, 2, Ono Pharmaceuticals, 5, Pfizer, 6.

To cite this abstract in AMA style:

Zeid J, Arce K, Guo N, Bhamidipati K, Wei K, Moreland L, Zhang F, Jonsson A. Granzyme K+ CD8 T cells colocalize with myeloid cells and activate them through several pathways [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/granzyme-k-cd8-t-cells-colocalize-with-myeloid-cells-and-activate-them-through-several-pathways/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/granzyme-k-cd8-t-cells-colocalize-with-myeloid-cells-and-activate-them-through-several-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology